Onconetix, Inc. (ONCO)
Onconetix Market Cap : 1.195M for Nov. 18, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 17, 2026 | 1.138M |
| November 16, 2026 | 1.104M |
| November 13, 2026 | 1.218M |
| November 12, 2026 | 1.150M |
| November 11, 2026 | 1.426M |
| November 10, 2026 | 1.316M |
| November 09, 2026 | 1.358M |
| November 06, 2026 | 2.637M |
| November 05, 2026 | 2.083M |
| November 04, 2026 | 2.498M |
| November 03, 2026 | 2.159M |
| November 02, 2026 | 20.59M |
| October 30, 2026 | 21.28M |
| October 29, 2026 | 22.23M |
| October 28, 2026 | 22.68M |
| October 27, 2026 | 18.00M |
| October 26, 2026 | 15.14M |
| October 23, 2026 | 15.86M |
| October 22, 2026 | 15.43M |
| October 21, 2026 | 16.51M |
| October 20, 2026 | 15.42M |
| October 19, 2026 | 16.32M |
| October 16, 2026 | 18.16M |
| October 15, 2026 | 20.79M |
| October 14, 2026 | 20.79M |
| Date | Value |
|---|---|
| October 13, 2026 | 21.06M |
| October 12, 2026 | 22.40M |
| October 09, 2026 | 23.52M |
| October 08, 2026 | 24.82M |
| October 07, 2026 | 22.66M |
| October 06, 2026 | 25.08M |
| October 05, 2026 | 25.53M |
| October 02, 2026 | 27.83M |
| October 01, 2026 | 28.23M |
| September 30, 2026 | 29.68M |
| September 29, 2026 | 31.11M |
| September 28, 2026 | 42.11M |
| September 25, 2026 | 39.08M |
| September 24, 2026 | 34.56M |
| September 23, 2026 | 34.52M |
| September 22, 2026 | 25.91M |
| September 21, 2026 | 24.84M |
| September 18, 2026 | 24.24M |
| September 17, 2026 | 25.17M |
| September 16, 2026 | 25.17M |
| September 15, 2026 | 24.48M |
| September 14, 2026 | 24.18M |
| September 11, 2026 | 28.70M |
| September 10, 2026 | 29.67M |
| September 09, 2026 | 30.85M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Vistagen Therapeutics, Inc. | 8.867M |
| BridgeBio Pharma, Inc. | 15.29B |
| ACADIA Pharmaceuticals, Inc. | 3.082B |
| Alnylam Pharmaceuticals, Inc. | 20.01B |
| Anika Therapeutics, Inc. | 182.43M |
Market Cap Related Metrics
| PS Ratio | 0.2884 |
| Price to Book Value | 0.0887 |
| Price | 3.15 |
| Earnings Yield | -63.21K% |